Apple loses bid to overturn $634 million Masimo patent verdict
Key Points:
- Apple’s attempts to overturn a $634 million patent infringement verdict in its legal battle with medical tech company Masimo were denied by U.S. District Judge James V. Selna.
- The dispute centers on Masimo’s claims that Apple Watch infringed patents related to pulse oximetry and optical health-monitoring technologies, with the jury ruling that the Apple Watch qualifies as a “patient-monitoring device” under the patent.
- Apple argued the term “patient monitor” should apply only to traditional medical equipment, but the judge upheld the broader interpretation supporting Masimo’s claims.
- Apple also failed in its request for a new trial, with the judge rejecting challenges to jury instructions and expert testimony exclusions as insufficient grounds for retrial.
- Apple maintains that most of Masimo’s patents have been invalidated, plans to appeal the ruling, and notes the patent in question expired in 2022 and pertains to outdated technology.